Influencer's Son Disputes Father's Death Cause in Thailand
British-Nigerian influencer Igho Ubiribo died in March following genital filler injections at a Thailand clinic, but his son now disputes the pulmonary embolism diagnosis and alleges murder without providing evidence.
British-Nigerian businessman and influencer Igho "Tiny" Ubiribo died after undergoing filler injections to enlarge his genitals in Thailand, with reports initially attributing his death to pulmonary embolism. On September 10, 2025, Nigerian news outlet Vanguard reported that Junior Ubiribo, Igho's son, challenged the official account of his father's death, stating there were many unresolved questions about the reported cause. Junior claimed his father was murdered in March and disagreed with the narrative that he died from the cosmetic procedure. He alleged his father sustained severe injuries, including the loss of one eye and a deep wound on his forehead, and questioned how such injuries could result from a medical procedure in Thailand. Junior also expressed concern about missing property and assets after his father's death, including a gun and watch, and accused his father's wife of taking them. He insisted his father deserved better and demanded a proper investigation to establish clear facts about the death. However, Junior's allegations remain unsubstantiated, with no independent evidence confirming murder, injuries, or missing property. The matter requires clarification from relevant authorities and involved parties. On September 7, 2025, officials from the Department of Health Service Support and the Food and Drug Administration inspected the clinic where Ubiribo received treatment. The clinic confirmed Ubiribo had been a patient since 2567 (2024) and had undergone five genital enlargement procedures. The fifth procedure occurred on March 5, 2025, when he received 40 cc of filler in a single injection despite the physician's recommendation to split the dose into two sessions. The clinic stated it provided post-procedure care instructions and follow-up monitoring, and that the patient signed informed consent forms before each procedure without reporting any complications.